A biotech start-up says the ovaries may hold clues to aging — a finding that could reshape IVF while opening a frontier in ...
The BioMarin Pharmaceutical Inc. acquisition of Amicus Therapeutics, Inc. will likely be beneficial and accretive for both ...
This study offers important insight into the pathogenic basis of intragenic frameshift deletions in the carboxy-terminal domain of MECP2, which account for some Rett syndrome cases, yet similar ...
The leading cause of death due to injuries in war is excessive bleeding. A KAIST research team, in which an Army Major ...
Microglia help protect the brain from damage and infection, but when they become overly active, they can also contribute to ...
Two inexpensive commercial materials store solar energy as electrons and release hydrogen fuel on demand in darkness, requiring no external power and setting a new performance record.
Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and ...
The phrase "come back" takes on a dual meaning in Pluribus, shifting from Carol's lonely plea on the pavement to Manousos' ...
Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...
The U.S. Food and Drug Administration (FDA) on Wednesday approved Omeros Corporation (NASDAQ: OMER) Yartemlea ...
Every once in a while, a secular trend is so obvious that everyone can see it, and that is the case with AI. Read more here.
A new study published today in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer Center details a therapeutic vulnerability in patients with an aggressive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback